1. Home
  2. TXG vs PAHC Comparison

TXG vs PAHC Comparison

Compare TXG & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXG
  • PAHC
  • Stock Information
  • Founded
  • TXG 2012
  • PAHC 1946
  • Country
  • TXG United States
  • PAHC United States
  • Employees
  • TXG N/A
  • PAHC N/A
  • Industry
  • TXG Biotechnology: Laboratory Analytical Instruments
  • PAHC Biotechnology: Pharmaceutical Preparations
  • Sector
  • TXG Industrials
  • PAHC Health Care
  • Exchange
  • TXG Nasdaq
  • PAHC Nasdaq
  • Market Cap
  • TXG 1.1B
  • PAHC 989.8M
  • IPO Year
  • TXG 2019
  • PAHC 2014
  • Fundamental
  • Price
  • TXG $10.65
  • PAHC $24.34
  • Analyst Decision
  • TXG Buy
  • PAHC Sell
  • Analyst Count
  • TXG 15
  • PAHC 4
  • Target Price
  • TXG $15.81
  • PAHC $20.00
  • AVG Volume (30 Days)
  • TXG 3.7M
  • PAHC 243.5K
  • Earning Date
  • TXG 08-07-2025
  • PAHC 05-07-2025
  • Dividend Yield
  • TXG N/A
  • PAHC 1.99%
  • EPS Growth
  • TXG N/A
  • PAHC 140.17
  • EPS
  • TXG N/A
  • PAHC 0.78
  • Revenue
  • TXG $624,662,000.00
  • PAHC $1,190,682,000.00
  • Revenue This Year
  • TXG N/A
  • PAHC $28.33
  • Revenue Next Year
  • TXG $5.70
  • PAHC $13.78
  • P/E Ratio
  • TXG N/A
  • PAHC $30.96
  • Revenue Growth
  • TXG N/A
  • PAHC 19.12
  • 52 Week Low
  • TXG $6.78
  • PAHC $16.16
  • 52 Week High
  • TXG $24.76
  • PAHC $26.55
  • Technical
  • Relative Strength Index (RSI)
  • TXG 66.58
  • PAHC 62.36
  • Support Level
  • TXG $8.95
  • PAHC $23.68
  • Resistance Level
  • TXG $9.79
  • PAHC $24.56
  • Average True Range (ATR)
  • TXG 0.54
  • PAHC 0.79
  • MACD
  • TXG 0.15
  • PAHC -0.15
  • Stochastic Oscillator
  • TXG 96.64
  • PAHC 66.67

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: